Full Press Release Details
REGENERON REPORTS PHASE II RESULTS FOR IL-1 TRAP CLINICAL PROGRAM IN RHEUMATOID ARTHRITIS IL-1 Trap Phase II Study Demonstrates Clinical Activity and Favorable Safety and Tolerability Profile.
REGN
REGENERON REPORTS PHASE II RESULTS FOR IL-1 TRAP CLINICAL PROGRAM IN RHEUMATOID ARTHRITIS IL-1 Trap Phase II Study Demonstrates Clinical Activity and Favorable Safety and Tolerability Profile
Key Takeaway: REGENERON REPORTS PHASE II RESULTS FOR IL-1 TRAP CLINICAL PROGRAM IN RHEUMATOID ARTHRITIS IL-1 Trap Phase II Study Demonstrates Clinical Activity and Favorable Safety and Tolerability Profile